Consensus definitions for invasive fungal disease: Strengths, limitations, and revisions

被引:7
作者
Donnelly, J. Peter
机构
[1] Radboud Univ Nijmegen, Univ Med Ctr St Radboud, Dept Hematol, NL-6525 GA Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Univ Med Ctr St Radboud, Nijmegen Univ Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands
关键词
definitions; invasive fungal diseases; aspergillosis; consensus;
D O I
10.1080/13693780600826707
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The European Organization for Research and Treatment of Cancer (EORTC)/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (MSG) consensus definitions for opportunistic invasive fungal infections have achieved their objective in fostering better communication between researchers but their limitations necessitated revision. In the last two years a group of experts drawn from both sides of the Atlantic have agreed a proposal for a new set of definitions that attempt to rectify omissions and problems arising from the original set whilst preserving their basic principles.
引用
收藏
页码:S285 / S288
页数:4
相关论文
共 19 条
[1]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[2]  
CORNELY OA, 2006, BLOOD, V106, P3222
[3]   Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed? [J].
de Pauw, BE ;
Patterson, TF .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S377-S380
[4]   British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections [J].
Denning, DW ;
Kibbler, CC ;
Barnes, RA .
LANCET INFECTIOUS DISEASES, 2003, 3 (04) :230-240
[5]   Polymerase chain reaction for diagnosing invasive aspergillosis: Getting closer but still a ways to go [J].
Donnelly, JP .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (04) :487-489
[6]   Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia [J].
Halliday, C ;
Hoile, R ;
Sorrell, T ;
James, G ;
Yadav, S ;
Shaw, P ;
Bleakley, M ;
Bradstock, K ;
Chen, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (04) :478-486
[7]   Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].
Herbrecht, R ;
Denning, DW ;
Patterson, TF ;
Bennett, JE ;
Greene, RE ;
Oestmann, JW ;
Kern, WV ;
Marr, KA ;
Ribaud, P ;
Lortholary, O ;
Sylvester, R ;
Rubin, RH ;
Wingard, JR ;
Stark, P ;
Durand, C ;
Caillot, D ;
Thiel, E ;
Chandrasekar, PH ;
Hodges, MR ;
Schlamm, HT ;
Troke, PF ;
de Pauw, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415
[8]   The invasive and saprophytic syndromes due to Aspergillus spp. [J].
Hope, WW ;
Walsh, TJ ;
Denning, DW .
MEDICAL MYCOLOGY, 2005, 43 :S207-S238
[9]   Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders [J].
Kawazu, M ;
Kanda, Y ;
Nannya, Y ;
Aoki, K ;
Kurokawa, M ;
Chiba, S ;
Motokura, T ;
Hirai, H ;
Ogawa, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2733-2741
[10]   Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study [J].
Maertens, J ;
Theunissen, K ;
Verhoef, G ;
Verschakelen, J ;
Lagrou, K ;
Verbeken, E ;
Wilmer, A ;
Verhaegen, J ;
Boogaerts, M ;
Van Eldere, J .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (09) :1242-1250